TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06918561: A Randomized Controlled Multisite Crossover Trial Evaluating the Efficacy of NeoThelium FT in the Treatment of "Other" Open Wounds

Sponsor: NuScience Medical Biologics, LLC · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 132 pts

Competing Trials Overlap

9 Active Trials

Excess Burn Exposure

$6,540,400

Rescue Site Savings

+$4,316,000

Unlock Full NCT06918561 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06918561 Rescue Dossier →